Find a consultant

Our consultant directory offers information on who our consultants are, their specialities and where they are based.

If you have an enquiry relating to your appointment or your treatment, you should contact the relevant department instead of your individual consultant to ensure that our clinical support team can provide you with the right support to your enquiry in a timely manner.

Ms Rifca Le Dieu

Consultant at St Bartholomew's Hospital

Rifca Le Dieu is an Honorary Consultant at Barts Health NHS Trust where she has an outpatient lymphoma practice. She also has a teaching role as a Clinical Reader in Haemato-Oncology at Barts Cancer Institute where she is the module organiser for 2 undergraduate biomedical science modules and is the Cancer Theme Lead for the MBBS programme.

Rifca trained at St John’s College, Cambridge and Imperial College, London before completing Haematology specialist training in NW London. Her subsequent research focussed on the microenvironment in cancer, an area in which she has several publications. Prior to starting her consultant post, she was a stem cell transplant coordinator at Hammersmith Hospital.

Since joining Barts, Rifca has taken an active interest in clinical trials and is a PI on several Hodgkin’s studies. She is a member the NCRI Hodgkin Lymphoma subgroup. In 2020, she contributed to a BJH international review on ‘How I treat advanced Hodgkin lymphoma’.

As part of her passionate advocacy of flexible working for medical staff in the NHS, Rifca is also the Barts Health Champion of Flexible Working, sits on the AoMRC Flexible Careers Committee and is a member of the NHS Flexible Working Reference Group. 

Research interests

How I treat advanced Hodgkin lymphoma - a global view

Peter Hokland, Mansi Shah, Kevin David, Andrew Evens, Rebecca Auer, Rifca Ledieu, Stefanie Kreissl, Paul J Bröckelmann, Peter Borchmann, Anu Korula, Vikram Mathews, Weerapat Owattanapanich, Judith Trotman, Br J Haematol. 2020 Sep;190(6):837-850. 

Clinical outcome of coronavirus disease 2019 in haemato-oncology patients

James A Aries, Jeffrey K Davies, Rebecca L Auer, Simon L Hallam, Silvia Montoto, Matthew Smith, Belen Sevillano, Vanessa Foggo, Bela Wrench, Krzysztof Zegocki , Samir Agrawal, Rifca Le Dieu, Edward Truelove, Thomas Erblich, Shamzah Araf, Jessica Okosun, Heather Oakervee, Jamie D Cavenagh, John G Gribben, John C Riches Br J Haematol. 2020 Jul;190(2): 2020 Jun 10.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting

Eyre TA, Phillips EH, Linton KM, Arumainathan A, Kassam S, Gibb A, Allibone S, Radford J, Peggs K, Burton C, Stewart G, LeDieu R, Booth C, Osborne WL, Miall F, Eyre DW, Ardeshna KM, Collins GP. Br J Haematol. 2017 Nov;179(3):471-47

Leadership roles

  • Barts Health Champion of Flexible Working
  • Barts Health SuppoRTT Lead
     
Speciality
Consultant services Cancer
Languages Spoken English
GMC number 4529387
Record last modified